二人麻将3d

Technology

  • DNA Encoded Library (DEL) is an innovative drug discovery technology rapidly gaining wide spread interest in the pharmaceutical industry in recent years. It combines the power of molecular biology, combinatorial chemistry, high throughput sequencing and advanced informatics to create vast number of novel molecules for hit identification and lead generation. HitGen has been building a large collection of novel, diverse and drug-like DELs as its primary drug discovery platform.


  • Read More

Pipeline

  • Currently HitGen has more than 20 internal projects in research, with 1 in Phase I, 2 in PCC generation and 2 in lead generation,mainly focused on oncology, CVD, inflammation/ respiratory, metabolism and ophthalmology.
  • Read More
Target Project Progress Therapeutic Area
Target: Deacetylase Target: Phosphatase Target: Dehydrogenase Target: Dioxygenase Target: Kinase Target: Protease Target: Lipase Target: Methyltransferase Target: GPCR Target:  Protein Protein Interaction Project progress: Target Preparation Project progress: Target Screening Project progress: Hit Validation Project progress: Hit2Lead Optimization Project progress: Lead Optimization Project progress: PCC generation Therapeutic Area: Ophthalmology Therapeutic Area: Metabolism Therapeutic Area: Inflammation/Respiratory Therapeutic Area: Cardiovascular Therapeutic Area: Oncology
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 1
  • 2
  • 3
  • 4
  • 5

Partnering

  • 01

    DNA Encoded Library Screening
    HitGen will screen its most up to date proprietary DELs (hundreds of billions of novel small molecules and macrocycles) against targets provided by the partners.
  • 02

    Custom DNA Encoded Library Synthesis
    HitGen will be responsible for the design and synthsis of DNA encoded library base on partner's specification. 
  • 03

    Innovative Drug Project Collaboration

    HitGen initiates a number of innovative drug discovery projects. These projects can be the subject of collaboration, which cover the areas of oncology, CVD, inflammation/ respiratory, metabolism and ophthalmology.


Read More
  • Careers

  • Here, we build future together! 

    Here, we create innovative medicine for patients!

  • Read More
二人麻将3d
麻将里面的万条筒是什么 k10全天二期计划在线 小米公司是靠什么赚钱 七星彩历史开奖数据 快乐十分首页 彩票计划软件app下载安装 牛牛棋牌游戏名叫什么 黑龙江22选5开奖号 九亿娱乐手机端 北京pk10 6码2期计划